Decent, safe work
B (68)
Screens
Advertising
Alcohol
Anti-abortion support
Cannabis
Carbon emissions intensity
Coal
Deforestation - financing
Deforestation - supply chain
Discrimination controversies
Environmental controversies
Factory farming
Fast food
Firearms
For-profit health care
Fossil fuel
Fur
Gambling
Genetic engineering
Human rights controversies
Human trafficking
Interest-based products
Interest-bearing debt
Interest-bearing securities
Music
Myanmar
Norges Bank exclusion list
Northern Ireland (Macbride)
North Korea
No SBTI commitment
Nuclear
Oil and gas
Opioid controversies
Oppressive governments
Pork
Pornography
Predatory lending
Prison involvement
Privacy breaches
Single-use plastic
Stem cell research
Sugar
Tobacco
Undermining US elections
Weapons
Impact

Cause ABT
Peer rank
Decent, safe work

Name Rating
Loading...
Screens
Advertising
Alcohol
Anti-abortion support
Cannabis
Carbon emissions intensity
Coal
Deforestation - financing
Deforestation - supply chain
Discrimination controversies
Environmental controversies
Factory farming
Fast food
Firearms
For-profit health care
Fossil fuel
Fur
Gambling
Genetic engineering
Human rights controversies
Human trafficking
Interest-based products
Interest-bearing debt
Interest-bearing securities
Music
Myanmar
Norges Bank exclusion list
Northern Ireland (Macbride)
North Korea
No SBTI commitment
Nuclear
Oil and gas
Opioid controversies
Oppressive governments
Pork
Pornography
Predatory lending
Prison involvement
Privacy breaches
Single-use plastic
Stem cell research
Sugar
Tobacco
Undermining US elections
Weapons
Top metrics
Sample of top metrics driving Abbott's rating for decent, safe work opportunities (B, relative to other companies). Hover or click on a bubble for more info. See details for all metrics in table below
Loading...
All metrics
Metrics used to rate Abbott for decent, safe work opportunities. Click on a metric for more info
Metric Source Data Normalized
Loading...

Data status

Summary statistics on data used to rate Abbott for decent, safe work opportunities

...

of potential metrics used

...

unique data

...

peer-average data

2 days ago

last updated

...

company filings data

...

government data

...

Ethos research

...

independent organization data
Controversies
Controversies associated with Abbott. Click on a controversy for more info
Title Date Severity
Loading...
* Indicates data is an average of peer group, or industry if peer data not available. Used when data for company not available.
Normalized scores are relative to other companies. Learn more about our ratings methodology
Note that all controversies information is based on publicly-available information.
ABT Price
$106.96
Last available end-of-day price. Full disclosure
Revenue
$45.03 billion
Market cap
$170.99 billion
Public/private
Public
Hypothetical historical growth of $10,000
Historical performance
Company
Founded
1991
Employees
113,000
Sector
Healthcare
Industry
Healthcare Equipment
Peer group
Medical Equipment - Major Diversified
Headquarters
Illinois, United States
Share classes
ABT
Mission
Committed to helping you live your best possible life through the power of health.
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Material causes
Ethos considers the following causes material for Abbott, based on its industry peer group Medical Equipment - Major Diversified. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.